Validation of a Prediction Rule for Mortality in Congenital Diaphragmatic Hernia

• Published in: Pediatrics (Evanston) Vol. 145; no. 4; p. 1
• Main Authors: Cochius-den Otter, Suzan C M, Erdem, Özge, van Rosmalen, Joost, Schaible, Thomas, Peters, Nina C J, Cohen-Overbeek, Titia E, Capolupo, Irma, Falk, Carolin J, van Heijst, Arno F J, Schäffelder, Regina, Brindle, Mary E, Tibboel, Dick
• Format: Journal Article
• Language: English
• Published: United States American Academy of Pediatrics 01.04.2020
• Subjects: Apgar score; Hernia; Hernias; Liver; Mortality; Neonates; Pediatrics; Predictions; Prenatal development
• ISSN: 0031-4005; 1098-4275
• DOI: 10.1542/peds.2019-2379

Congenital diaphragmatic hernia (CDH) is a rare congenital anomaly with a mortality of ∼27%. The Congenital Diaphragmatic Hernia Study Group (CDHSG) developed a simple postnatal clinical prediction rule to predict mortality in newborns with CDH. Our aim for this study is to externally validate the CDHSG rule in the European population and to improve its prediction of mortality by adding prenatal variables. We performed a European multicenter retrospective cohort study and included all newborns diagnosed with unilateral CDH who were born between 2008 and 2015. Newborns born from November 2011 onward were included for the external validation of the rule ( = 343). To improve the prediction rule, we included all patients born between 2008 and 2015 ( = 620) with prenatally diagnosed CDH and collected pre- and postnatal variables. We build a logistic regression model and performed bootstrap resampling and computed calibration plots. With our validation data set, the CDHSG rule had an area under the curve of 79.0%, revealing a fair predictive performance. For the new prediction rule, prenatal herniation of the liver was added, and absent 5-minute Apgar score was taken out. The new prediction rule revealed good calibration, and with an area under the curve of 84.6%, it had good discriminative abilities. In this study, we externally validated the CDHSG rule for the European population, which revealed fair predictive performance. The modified rule, with prenatal liver herniation as an additional variable, appears to further improve the model's ability to predict mortality in a population of patients with prenatally diagnosed CDH.